当前位置: 首页 > 期刊 > 《中国现代医生》 > 2012年第32期
编号:12331205
胃癌相关细胞因子的研究进展(3)
http://www.100md.com 2012年11月15日 《中国现代医生》 2012年第32期
     [13] Zaidi SF,Ahmed K,Yamamoto T,et al. Effect of reseratrol on Helicobacter pylori-induced interleukin-8 secretion, reactive oxygen species generation and morphological changes in human gastric epithelial cells[J]. Biol Pharm Bull,2009,32:1931-1935.

    [14] Hussain SP,Harris CC. Inflammation and cancer: an ancient link with novel potentials[J]. Int J Cancer,2007,121:2373-2380.

    [15] Kido S,Kitadai Y,Hattori N,et al. Interleukin-8 and vascular endothelial growth factor-prognostic factors in human gastric carcinomas[J]. Eur J Cancer,2001,37:1482-1487.

    [16] Konno H,Ohta M,Baba M,et al. The role of circulate IL-8 and VEGF protein in the progression of gastric cancer[J]. Cancer Sci,2003,94:735-740.

    [17] Song B,Zhang D,Wang S,et al. Association of interleukin-8 with cachexia from patients with low-third gastric cancer[J]. Comp Funct Genomics,2009:212345.

    [18] 孙宝峰. 胃癌患者血清IL-6、IL-8、TNF-α水平变化及意义[J]. 山东医药,2010,50(38):69-70.

    [19] 张天彪,赵滢,关一夫. TNF-α和EGFR在胃癌中表达的相关性研究[J]. 山东医药,2010,50(20):63-64.

    [20] Ha H,Han D,Choi Y. TRAF-mediated TNFR-family signaling[J]. Curt Protoc Immunol,2009,Chapter 11:Unitl1.9D.

    [21] 刘健,宋璐,王昌高,等. 胃癌患者肿瘤坏死因子基因型与其血清水平的关系[J]. 中华消化杂志,2012,32(4):226-231.

    (收稿日期:2012-08-02)

    , 百拇医药(邱磊 付海啸 宋军 徐为)
上一页1 2 3